| Literature DB >> 26177542 |
Jennifer Straatman1, Annelieke M K Harmsen1, Miguel A Cuesta1, Johannes Berkhof2, Elise P Jansma3, Donald L van der Peet1.
Abstract
BACKGROUND: Early diagnosis and treatment of complications after major abdominal surgery can decrease associated morbidity and mortality. Postoperative CRP levels have shown a strong correlation with complications. Aim of this systematic review and pooled-analysis was to assess postoperative values of CRP as a marker for major complications and construct a prediction model. STUDYEntities:
Mesh:
Substances:
Year: 2015 PMID: 26177542 PMCID: PMC4503561 DOI: 10.1371/journal.pone.0132995
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart for literature search.
Overview of definitions used for complications and anastomotic leakage in the selected studies.
Abreviations; postoperative day (POD), anastomotic leak (AL), systemic inflammatory response syndrome (SIRS), computed tomography scan (CT), urinary tract infection (UTI).
|
| |||||
| Study |
|
|
|
|
|
| Adamina [ | 2014 | Colorectal | 56 mg/L | 4 | Infectious complications, graded according to Clavien-Dindo. Cut-off applies in absence of clinical signs. |
| Kørner [ | 2009 | Colorectal | 190 mg/L | 3 | Intraabdominal infection; AL, abscess or diffuse peritonitis |
| Lane [ | 2012 | Colorectal | 150 mg/L | 2 | Adverse events: including infective complications, postoperative organ dysfunction and prolonged length of stay |
| MacKay [ | 2009 | Colorectal | 145 mg/L | 4 | All infective complications |
| Mokart [ | 2005 | All abdominal | 93 mg/L | 1 | Postoperative sepsis (SIRS + infection) |
| Nason [ | 2014 | Colorectal | 148 mg/L | 4 | Infective complications; AL confirmed by CT, wound infection with purulent drainage |
| Platt [ | 2012 | Colorectal | 170 mg/L | 3 | Postoperative infective complications (surgical site and remote site infection) |
| Straatman [ | 2014 | Major abdominal surgery | 145 mg/L | 3 | Postoperative complications defined by Clavien-Dindo, with a cut-off for major complications (grades 3 and up) |
| Warschkow [ | 2012 | Pancreas | 94 mg/L | 7 | Postoperative inflammatory complications; pancreatic fistula, anastomotic leak, cholangitis, pancreatitis, wound infections, abscesses, pneumonia, UTI |
| Warschkow [ | 2012 | Gastro-esophageal | 141 mg/L | 4 | Postoperative infections; AL, abscess, pneumonia, wound infection, UTI, colitis |
| Warschkow [ | 2012 | Colorectal | 135 mg/L | 4 | Postoperative infectious complications: Any septic event, both intra- and extra- abdominal infections |
| Warschkow [ | 2011 | Colorectal | 123 mg/L | 4 | Inflammatory complications; AL (confirmed by imaging or operation), UTI, wound infection, pneumonia, central line infections. |
| Welsch [ | 2008 | Pancreas | 140 mg/L | 4 | Fistula, leak, abscess, wound infection, pneumonia, cholangitis, central line infection, UTI, necrotizing pancreatitis, infectious bilioma or pleural effusion |
|
| |||||
|
|
|
|
|
|
|
| Almeida [ | 2012 | Colorectal | 140 mg/L | 3 | AL defined as free feacal fluid in the abdomen diagnosed by drain production or CT-scan imaging |
| Deitmar [ | 2009 | Oesophagus | 135 mg/L | 2 | Leak of anastomosis or gastric staple line confirmed with endoscopy |
| Dutta [ | 2011 | Esophago-gastric | 180 mg/L | 3 | AL confirmed with CT, contrast study or upor reoperation |
| Garcia-Granero [ | 2013 | Colorectal | 147 mg/L | 3 | AL confirmed with imaging or upon reoperation |
| Oberhofer [ | 2012 | Colorectal | 99 mg/L | 3 | AL (imaging), abscess, wound infection, pneumonia, central line infection, UTI |
| Ortega- Deballon [ | 2010 | Colorectal | 125 mg/L | 4 | AL: feacal drain production, collection at anastomosis site with imaging, dehiscence during reoperation |
| Pedersen [ | 2012 | Colorectal (MIS) | 200 mg/L | 3 | AL diagnosed in patients with acute abdomen, upon imaging or upon reoperation |
| Scepanovic [ | 2013 | Stomach, small bowel, colon | 135 mg/L | 3 | AL defined as clinical presence of enteric contents within the drains |
| Welsch [ | 2007 | Rectal | 140 mg/L | 3&4 | AL (imaging), abscess, wound infection, pneumonia, central line infection, UTI |
Characteristics of the studies included for pooled-analysis.
Abbreviations: months (mo), minimally invasive surgery (MIS).
| Study | Design | Study interval | Operation | Indication (acute/elective) | n | Major Complication |
|---|---|---|---|---|---|---|
| Almeida et at. (2012) [ | Retrospective | 22 mo | Colorectal resection | Both | 173 | 21 of 173 (12.1%) |
| Garcia-Granero et al. (2013)[ | Prospective | 17 mo | Colorectal resection | Both | 205 | 17 of 205 (8.3%) |
| Kørner et al. (2009) [ | Retrospective | 12 mo | Colorectal resection | Both | 231 | 23 of 231 (10%) |
| Lagoutte et al. (2012) [ | Retrospective | 14 mo | Colorectal resection | Both | 100 | 20 of 100 (20%) |
| Pedersenet al. (2012) [ | Retrospective | 12 mo | MIS Colorectal resection | Both | 163 | 41 of 163 (25.2%) |
| Scepanovic et al. (2013) [ | Prospective | 18 mo | Al digestive resections with anastomosis | Both | 156 | 15 of 156 (9.6%) |
| Straatman et al. (2014) [ | Retrospective | 24 mo | All digestive resections with anastomosis/ostomy | Both | 399 | 82 of 399 (20.6%) |
The QUADAS tool for classification of accuracy of the studies selected from literature, according to number of studies in each response category.
| QUADAS criteria | Number of articles in each category | ||
|---|---|---|---|
| Yes No Unclear | |||
| Was the spectrum of patients representative of the patients who will receive the test in practice? | 7 | - | - |
| Were selection criteria clearly described? | 7 | - | - |
| Is the reference standard likely to correctly classify the target condition? RS: x, CT-scan of diag lap | 7 | - | - |
| Is the time period between reference standard and index test short enough to be reasonably sure that the target condition did not change between the two tests? | 7 | - | - |
| Did the whole sample or a random selection of the sample, receive verification using a reference standard of diagnosis? | - | 7 | - |
| Did patients receive the same reference standard regardless of the index test result? | 2 | 5 | - |
| Was the reference standard independent of the index test (i.e. the index test did not form part of the reference standard)? | 1 | 6 | - |
| Was the execution of the index test described in sufficient detail to permit replication of the test? | 4 | 3 | - |
| Was the execution of the reference standard described in sufficient detail to permit its replication? | 6 | 1 | - |
| Were the index test results interpreted without knowledge of the results of the reference standard? | 5 | 1 | 1 |
| Were the reference standard results interpreted without knowledge of the results of the index test? | 7 | ||
| Were the same clinical data available when test results were interpreted as would be available when the test is used in practice? | 7 | ||
| Were uninterpretable/ intermediate test results reported? | 1 | 5 | 1 |
| Were withdrawals from the study explained? | 2 | 4 | 1 |
Median CRP levels and interquartile ranges (IQR) for each postoperative day in the included studies for patients with major complications versus patients with an uncomplicated course or minor complication.
NA = Not Available
| Study | CRP POD 3 | CRP POD 4 | CRP POD 5 | |||
|---|---|---|---|---|---|---|
| Uncomplicated or minor complication | Major complication | Uncomplicated or minor complication | Major complication | Uncomplicated or minor complication | Major complication | |
| Almeida [ | 99 (78–122) | 167 (127–307) | 58 (37–93) | 179 (117–237) | 28 (22–35) | 124 (104–262) |
| Garcia-Granero [ | 125 (71–186) | 255 (188–270) | 85 (50–138) | 260 (120–278) | 56 (31–100) | 248 (137–285) |
| Korner [ | 113 (69–199) | 256 (180–317) | NA | NA | 54 (30–117) | 193 (95–313) |
| Lagoutte [ | 112 (83–170) | 227 (140–270) | 80 (50–127) | 160 (100–284) | NA | NA |
| Pedersen [ | NA | NA | NA | NA | 113 (69–223) | 194 (125–289) |
| Scepanovic [ | 114 (87–140) | 168 (113–195) | 79 (62–113) | 145 (84–190) | 57 (39–98) | 127 (61–157) |
| Straatman [ | 157 (108–229) | 245 (163–331) | 124 (82–171) | 189 (125–296) | 94 (54–172) | 159 (89–253) |
Fig 2Receiver Operator Characteristics (ROC) curve for CRP levels on postoperative day (POD) 3,4 and 5.
Receiver Operator Characteristics (ROC) curve analysis for pooled data with area under the curve (AUC), positive predictive values(PPV) and negative predictive values (NPV) for each postoperative day (POD).
Positive and negative likelihood ratios (LR+ and LR-) were calculated to assess the difference in odds of complications pre- and post CRP measurement.
| POD | cut-off | AUC | 95% CI | Sensitivity | Specificity | PPV | NPV | LR+ | LR- |
|---|---|---|---|---|---|---|---|---|---|
| POD 3 | 140 | 0.783 | 0.742–0.824 | 81.7% | 61.6% | 25.7% | 95.4% | 2.13 | 0.30 |
| POD 4 | 130 | 0.79 | 0.744–0.836 | 71.4% | 72.5% | 31.6% | 93.4% | 2.60 | 0.39 |
| POD 5 | 101 | 0.800 | 0.740–0.840 | 76.6% | 71.0% | 34.9% | 93.7% | 2.64 | 0.33 |
Fig 3Prediction for the probability of major complications as a function of measured CRP levels on postoperative day three, with 95% confidence interval.
Depicts probability of complications for individual CRP measurements.
Probability of major complications for different CRP levels, with the probability of the upper cut-off of 215 mg/L depicted.
| CRP level | Probability | 95% confidence interval | |
|---|---|---|---|
| mg/L | % | Lower | Upper |
| 50 | 3.94% | 2.51% | 6.13% |
|
|
|
|
|
| 100 | 6.51% | 4.46% | 9.39% |
| 150 | 10.77% | 7.83% | 14.64% |
| 200 | 17.16% | 12.85% | 22.53% |
|
|
|
|
|
| 250 | 26.42% | 19.96% | 34.10% |
| 300 | 37.88% | 28.63% | 48.10% |
| 350 | 52.48% | 40.07% | 64.59% |
| 400 | 62.98% | 48.98% | 75.09% |